Ajankohtaista

Regulatory Affairs Specialist / Assistant – Thermo Fisher Scientific, Vantaa

1.5.2019 | Avoimet työpaikat

https://duunitori.fi/tyopaikat/tyo/regulatory-affairs-specialist-assistant-stshe-9561234

Työpaikkakuvaus

Regulatory Affairs Specialist / Assistant
Vantaa, Finland

Our in vitro diagnostic medical devices are regulated products which need marketing authorization before sales can commence. We are looking for a Regulatory Affairs Specialist /Assistant to coordinate product registrations in co-operation with our commercial organization and distributors. The selected candidate will work as an integral part of a multidisciplinary Quality Assurance and Regulatory Affairs team to coordinate and compile product registration packages to e.g. India and other Asia-Pacific countries. This is a fixed-term position for approximately 3-4 months.

What can we offer

  • Opportunity to gain experience in regulatory affairs and know-how in international regulations that is a core competence in medical device industry
  • Work in a multi-disciplinary and international setting both with Thermo Fisher Scientific colleagues and our customers
  • Possibility to work with our diverse in-vitro medical device product portfolio including clinical chemistry products and analyzers as well as laboratory automation solutions

How you’ll get there

  • M.Sc or B.Sc degree in microbiology, biology, analytical chemistry, biochemistry, engineering or related field, or a Student of the mentioned scientific disciplines
  • Motivation to learn and interpret different regulations related to in vitro diagnostic medical device industry
  • Excellent verbal and written communication skills in English
  • Sound organizational skills and attention to detail in documenting
  • Self-driven attitude with persistence to take projects to the completion

Please send in your application, including a cover letter and CV. Please apply via https://jobs.thermofisher.com/ by 12.5.2019. Reference: 93305BR. Please apply as soon as possible, the position will be filled as soon as suitable candidate is found.

Senior / Post-doctoral Scientists (Cancer and Immunotherapy) – Kuopio Center for Gene and Cell Therapy (KCT)

1.5.2019 | Avoimet työpaikat

https://www.sympahr.net/public/pq.aspx?1625e2a6&lang=en-US

Kuopio Center for Gene and Cell Therapy (KCT) is a world-renowned research institute located in Kuopio, Finland. Our mission is to conduct high-level research on basic and translational fields of gene- and cell therapy. The center’s niche is in the interface between academic research and the commercial biotechnology industry. KCT provides an exciting environment for applied research, discovering, establishing and developing them through Phase I clinical trials and utilizing some of the most advanced analytical and mechanistic proof-of-principle approaches in the sector.

We are seeking for two enthusiastic, highly motivated and skilled candidates with a background in disease or tumor biology, immunology and biomarker research for Senior Scientist (post-doctoral) role in Immunotherapy Program in Kuopio Center for Gene and Cell Therapy. Successful candidates will have an opportunity to work in one or more of the areas as project manager: T cell and NK cell biology, tumor microenvironment and/or discovery of novel tumor targets. The candidate will contribute to the projects experimentally and scientifically, provide his/her expertise, take-leading role in internal reporting and continue in a laboratory-focused role. The candidate will have a proven track record of scientific productivity and ability to participate in multidisciplinary and innovative research. The individual will participate in strategic discussions, national and international collaborations and coordinate project activities.

The selected candidates will be focused in work leading to the development of novel immunotherapies. The responsibilities include:

  • Effectively collaborate within the research center and national/international collaborators.
  • Lead the design and implementation experimentation.
  • Supervise young scientists and technicians working in the project.
  • Generate, analyze and interpret data. Demonstrate a high level of initiative in troubleshooting experiments and accurate data analysis. Objectively interpret data and provide conclusions regarding project results and direction.
  • Actively report research results and novelties in the field.

Qualifications: PhD in immunology, molecular/cell biology, cancer biology, pharmaceutical sciences or biomarker discovery OR MSc with at least 10 years of relevant experience. Knowledge on high-throughput experimentation and large data analysis is positively evaluated. Strong hands-on technical skills (e.g. primary cell isolation and culture, flow cytometry, live cell imaging) and reporting in research. Ability to multitask, manage and develop complex projects. Effective written and spoken English language skills. Excellent interpersonal and teamwork skills.

We offer an inspiring multicultural environment, constructed of our enthusiastic, highly skilled and experienced personnel in gene and cell therapy. Kuopio Center for Gene and Cell Therapy has established working links with the gene and cell therapy manufacturer FinVector, the A.I. Virtanen Institute for Molecular Sciences, the University of Eastern Finland, the National Laboratory Animal Center, and Kuopio University Hospital. These are situated on the same Kuopio health science focused campus, the capability of which to undertake gene and cell therapy research is made complete by the presence of the office of the Finnish Medicines Agency (Fimea). Finland has been ranked as the happiest country in the world and vibrant Kuopio, is rated as Finland’s best city to live in. It offers a safe living environment, friendly atmosphere and clean nature.

More information Cell Therapy Unit Director Tuija Kekarainen (tel. +358405376603 or tuija.kekarainen@kct.fi) and HR Director Johanna Pirinen (Johanna.pirinen@kct.fi). 

Please send your application before 20th May 2019.

The Department of Anesthesiology at Washington University School of Medicine welcomes applications for a tenure-track faculty position in The Center for Clinical Pharmacology

30.4.2019 | Avoimet työpaikat

The Department of Anesthesiology at Washington University School of Medicine welcomes applications for a tenure-track faculty position in The Center for Clinical Pharmacology, a multi-institutional research center established in partnership with with St Louis College of Pharmacy in 2015.  Successful candidates will join an existing group of faculty with research interests in basic and translational pharmacological science.

The goal of the Center for Clinical Pharmacology is to focus on human-oriented research that spans the continuum of basic to translational and clinical research, specifically through research that improves the use of both current and new therapeutics and diagnostics. The Center faculty brings vast experience in multiple aspects of drug discovery including drug mechanisms, medicinal chemistry, PK/PD, pharmacogenomics and drug development.  The Center has a deep interest in “chemical biology”, pharmacology, behavior and neuroscience.

This position is targeted at established investigators at the Associate Professor or Professor levels. Strong preference will be given to candidates currently conducting translational and/or clinical research. Additional leadership opportunities are available dependent upon experience. Successful candidates will be expected to direct an active extramurally funded research program and participate in graduate and/or postdoctoral education, with faculty appointments at both Washington University School of Medicine and the St Louis College of Pharmacy. Teaching opportunities are readily available but requirements are minimal, permitting a strong focus on research. Generous startup funds and newly constructed lab space are available. 

Candidates must have a doctoral degree (PharmD, PhD, MD or equivalent) and a demonstrated record of accomplishment as an independent investigator. Applications will be reviewed as received until the position is filled. 

To apply, send a curriculum vitae, a summary of past research activities, future research plans, and the names of three references to:

Karen Seibert, PhD, Executive Director, via email to clinpharm@anest.wustl.edu.
For more background see www.clinicalpharmstl.org

The Department of Anesthesiology at Washington University School of Medicine in St Louis fosters an academic culture in which clinical care, research, and education are seamlessly integrated. The department makes major contributions to the science of anesthesiology through its basic science and clinical science programs, which are heavily focused on innovative education and comprehensive, personalized clinical training.

Founded in 1864, St. Louis College of Pharmacy is the third-oldest and 10th-largest college of pharmacy in America. The College provides students unparalleled opportunities to learn through research, internships, and other hands-on learning experiences with their neighbors Barnes-Jewish Hospital, Washington University School of Medicine, and St. Louis Children’s Hospital.

Postdoctoral position(s) available on summer/autumn 2019 at Harvard Medical School and Cancer Center at Beth Israel Deaconess Medical Center

29.4.2019 | Avoimet työpaikat

Harvard Medical School and Cancer Center at Beth Israel Deaconess Medical Center

Postdoctoral position(s) available on summer/autumn 2019

Our lab studies how cancer cells develop drug resistance, and more specifically, how tumor microenvironment provides support and protection for tumor cells. Our aim is to develop better treatment strategies to overcome this tumor microenvironment mediated drug resistance. 

To investigate these topics we utilize both normal and cancer cells in 3D organoid culture systems, which mimic the architecture and organization of tissues. We use this platform in co-culture systems to understand how stromal and epithelial cells communicate with each other, and have also adopted the use of organoids for larger scale methodologies, such as proteomics, metabolomics, RNA-seq and ribosome foot-printing experiments to gain insight into multiple mechanisms by which cancer cells become drug resistant in 3D environments.

Our group is located in the Longwood medical area, at the Beth Israel Deaconess Medical Center, with several established collaborations with groups in the Harvard Medical School, MIT, Yale, Weill Cornell and MD Anderson. This environment provides unique opportunities for performing cutting-edge science, training in state-of-the-art technologies, forming new collaborations, and developing new technologies.

We are looking for highly motivated individual(s) who have recently finished (or about to finish) their PhD, with excellent communication and critical thinking skills, and who are able to work as part of a team. Training in cell biology, molecular biology and microscopy, and basic understanding of cell signaling networks is required.

For more information, please visit our lab web page: http://www.muranenlab.org

Or refer to the relevant publications: Muranen et al. Cancer Cell 2012, Muranen at al. Cancer Research 2016, Muranen et al. Nature Communications 2017 (http://rdcu.be/oqQ6).

Please send a cover letter with short description of your research interests and previous experience, current CV, and names of three references to tmuranen@bidmc.harvard.edu.

Postdoctoral fellow and PhD student positions in computational biology available at GrecoLab (Tampere University, Finland)

29.4.2019 | Avoimet työpaikat

The research group of associate professor Dario Greco at the Faculty of Medicine and Health Tehcnology and BioMediTech Institute at the Tampere University (Finland) focuses in advancing the fields of systems toxicology and predictive pharmacology using big data modelling and machine learning algorithms. We have a unique combination of expertise that spans systems biology, toxicology, cheminformatics and bioinformatics. Our vision is to push the state-of-the-art in predictive toxicology and pharmacology and subsequently address some of the major challenges arising in chemical safety assessment and drug development. We are seeking for highly motivated postdoctoral researcher and PhD student with a strong background in data mining, data modelling, biostatistics and machine learning.

The main tasks will include: integrating, analyzing and modelling large and diverse datasets comprising molecular descriptors and mechanism of action (OMICS data) of chemicals and nanomaterials; analyzing and modelling large OMICs data sets of molecular epidemiology; collaborating with other researchers in Finland and abroad.

The ideal candidates hold a M.Sc./Ph.D. in relevant disciplines with a strong publication record. Moreover she/he is an expert in at least one of the following: OMICS data analysis and integration, QSAR, read-across, statistical modelling, network inference.

Applications including

i)                    a research statement,

ii)                  a CV and

iii)                a cover letter including names of at least two referees,


can be sent via email to dario.greco(at)tuni.fi by the 30th of May 2019.

GrecoLab is currently involved in the large collaborative projects:

EU H2020 NanoSolveIT (http://www.nanosolveit.eu )

EU H2020 NanoinformaTIX

EU IMI2 BIOMAP

EU FP7 NANOSOLUTIONS (http://www.nanosolutionsfp7.com )

EU H2020 LIFEPATH (https://www.lifepathproject.eu )

EU H2020 CALIBRATE (http://www.nanocalibrate.eu )

Moreover, receives funding from the Academy of Finland and Business Finland.

GrecoLab info:

https://research.uta.fi/toxicology-and-pharmacology/
https://scholar.google.com/citations?user=gYQtSFkAAAAJ&hl=en
https://www.researchgate.net/profile/Dario_Greco

Postdoc position in the laboratory of Dr. Brady Atwood in the Department of Psychiatry at Indiana University School of Medicine

29.4.2019 | Avoimet työpaikat

The laboratory of Dr. Brady Atwood in the Department of Psychiatry at Indiana University School of Medicine is seeking to fill an immediate opening for a full-time post-doctoral appointee.

Candidates should possess a doctoral degree in neuroscience, pharmacology, physiology or a related field. The postdoc will have opportunities to learn patch clamp electrophysiology, in vitro and in vivo optogenetics and animal behavior paradigms.  

Research space will be in the new Neurosciences Building; investigators in this building have access to state-of-the-art Core Facilities. The department and the university place a high priority on creating a diverse learning environment and on supporting the professional development of ethnic minorities, women, veterans, and people with disabilities. Applications are encouraged from professionals of all ethnic backgrounds.

Please email Dr. Brady Atwood at bkatwood@iu.edu for further information. If interested, please email your CV and the contact information for at least 3 references. ​

Open position for a Senior Scientist (diagnostics and immuno assay development) in Biopromic AB, Solna, Sweden

29.4.2019 | Avoimet työpaikat

Make a real difference in the fight against infectious diseases. Biopromic AB (http://biopromic.com/ ) strive to develop Point of care testes for rapid diagnosis of infectious diseases. Our portfolio covers several important know-how and technologies for the development of different test platforms of importance in the fields of human and veterinary diagnostics.

Duties and responsibilities:

–        Responsible for the methodologies and make sure recipes are available.

–        Preparation of project-and validation documents and reports.

–        Expertise in immunoassays development (ELISA, Lateral flow and other), and provide technical support to the rest of the team.

–        Actively involved in troubleshooting in R&D daily work.

Requirements and qualifications:

–        PhD in Biomedical Science or equivalent.

–        At least 4 years experience as a scientist i a field of diagnostic research and development.

–        Experience in biochemistry, cell culturing, chromatography, assay development and validation and immunoassays.

–        Excellent command of the English language in both verbal and written,

–        Experience in development of monoclonal antibodies – from cell culture to purification and QC

–        Accountable: Prioritize your work and take responsibility for your own tasks and supporting others in the team.

–        Experience of work according to GMP is a merit.

–        Accurate and meticulous in daily work and delivering according to plan.

We look forward to reading your application with full CV!

Location: Solna/Stockholm, Sweden

Application deadline: 2019-05-15

Submit your application to: careers@biopromic.com  using a code SS2019 in the title of your email.

For more information contact us at: careers@biopromic.com

Postdoc position at Welcome-Wolfson Institute for Experimental Medicine, Queen´s University, Belfast

29.4.2019 | Avoimet työpaikat

FULLY FUNDED 2-YEAR POSTDOCTORAL POSITION IN THE VALVANO GROUP

A Postdoctoral Fellow position for an individual with training and demonstrated abilities in cell biology/cellular immunology/cellular microbiology is available in the Valvano group to investigate the inflammasome in human CFTR-defective macrophages and monocytes.

Project summary: Infection and chronic inflammation in patients with cystic fibrosis (CF) lead to progressive lung damage. CF-defective macrophages fail to kill engulfed opportunistic pathogens such as Burkholderia cenocepacia. Engulfed pathogens disarm macrophages and counteract immunity by deploying proteins (effectors) that alter central cellular pathways including actin cytoskeleton remodeling. Pathogen-induced disorganization of the actin cytoskeleton is both a remarkable anti-host strategy and a danger signal driving inflammation and cell death. However, the actin cytoskeleton dynamics in the context of the CF defect has not been explored. We hypothesize that intracellular opportunistic pathogens engulfed by macrophages, in combination with the CF genetic defect, induce disorganization of the actin cytoskeleton that leads to a

highly proinflammatory state. Our research established B. cenocepacia as a model organism for cellular microbiology. We discovered that a B. cenocepacia type VI-secretion system (T6SS) disrupts the macrophage’s actin cytoskeleton and elicits pyroptosis (proinflammatory cell death), and we recently identified TecA as the T6SS protein responsible for these phenotypes by causing the direct inactivation of Rho GTPases, which in turn activates the Pyrin inflammasome and the ASC complex formation. We will

investigate here the relationship between inflammation and B. cenocepacia-mediated modulation of macrophages’ actin cytoskeleton in CFTR-defective human monocytic macrophages. We will address 2 specific aims: (1) To assess the status of the pyrin inflammasome in B. cenocepacia-infected, CFTRdefective peripheral monocytes; and (2) To evaluate the role of the B. cenocepacia T4SS and T2SS systems in the activation of ASC-dependent inflammasomes upon infection in human macrophages.

Interested applicants should contact Prof. Miguel A. Valvano at m.valvano@qub.ac.uk and provide a CV, brief statement of interest, and references.

Open position for an Assistant/Associate Professor / Professor, Emerging Infectious Diseases, HOH Helsinki One Health

29.4.2019 | Avoimet työpaikat

The University of Helsinki is an international scientific community of 40,000 students and researchers. It is one of the leading multidisciplinary research universities in Europe and ranks among the top 100 international universities in the world.

HOH Helsinki One Health is a new network organization, led by the Faculty of Veterinary Medicine and cooperated by four other faculties at the University of Helsinki, to co-ordinate research actions within the area of One Health. One Health is a globally emerging concept recognizing that the health of humans and animals is interconnected and that their populations share the essentials of life: the genome, disease causing organisms, health, welfare, and the environment. HOH Helsinki One Health involves different disciplines and professions to work together to resolve emerging health problems concerning human and animal populations worldwide. In addition to other profiling actions, HOH Helsinki One Health will host several tenure track professorships with their established research environments in years 2018-2022. Please see: https://www.helsinki.fi/en/one-health.

We invite applications for the position of an

ASSISTANT PROFESSOR / ASSOCIATE PROFESSOR / PROFESSOR IN EMERGING INFECTIOUS DISEASES

This is a joint position between the Faculty of Medicine and the Faculty of Veterinary Medicine. The research and teaching field of the professorship is microbiology, infectious diseases and vaccines.

More information and application at https://www.helsinki.fi/en/open-positions/assistant-professor-associate-professor-professor-in-emerging-infectious-diseases-hoh-helsinki-one-health

Deadline for applications is May 26, 2019.

Blueprint Genetics is looking for a Geneticist (Clinical Interpretation, Helsinki)

9.4.2019 | Avoimet työpaikat

Introduction
Blueprint Genetics is on a mission to bring world-class genetic knowledge to mainstream healthcare. To meet the challenges imposed by our rapid growth, we are looking for new Geneticists to join our Clinical Interpretation Team. We are a team of experienced professionals with diverse backgrounds who share the passion for helping patients and families suffering from inherited disorders. Our constantly evolving diagnostic portfolio currently includes over 200 tests that cover a wide variety of clinical specialties and diagnostic approaches, including Whole Exome Sequencing. We work with hundreds of clinics around the globe and the quality of our interpretation has been praised by many of the world’s best medical centers. If you have the ambition to be among the pioneers of the molecular era of medicine, you might be the person we are looking for.

Job description
The position involves interpretation and reporting of findings from our clinical molecular genetic tests, including panel-based tests, Whole Exome Sequencing and targeted variant tests. Our Geneticists also participate in the development and validation of products and applications in a project team environment. Those interested get to collaborate with our Software Engineers and Data Scientists with the development of our proprietary software tools that enable us to interpret identified variants efficiently by utilizing artificial intelligence and machine learning.

The ideal candidate has:

  • Clinical Laboratory Geneticist degree or Board certification in Clinical Molecular Genetics / Laboratory Genetics and Genomics or Ph.D. in Genetics.
  • Experience in interpreting and reporting genetic test results in a clinical setting utilizing NGS, Sanger sequencing and other methods is an asset, but similar research experience is valued as well.
  • Knowledge of current genomic information and variant databases is essential
  • Fluent skills in oral and written English are a necessity
  • Great attention to detail
  • Critical thinking when reviewing scientific literature
  • Effective planning and organization skills
  • Excellent follow-through abilities
  • Experience in working under certified and accredited quality management systems is an asset.
  • Fitting the immediate, low-hierarchy and positive Blueprint culture

What we offer
At Blueprint Genetics, you get to be a valued part of our global and multidisciplinary team of people who want to make a difference. You will be working daily to bring your expertise from base pairs to bedside for improved patient outcomes. We offer you a rapidly evolving working environment where you can learn and grow together with a unique company and great colleagues. You get to use everything you have learned in an environment that is unlike anything you have experienced before.

The position is permanent full-time position.

More information and application at https://careers.blueprintgenetics.com/jobs/212558-geneticist